Anhui BBCA Pharmaceutical Co., Ltd.

Company Description

The mainstay subsidiary of the BBCA Group, Anhui BBCA Pharmaceutical Co., Ltd. located in Hefei City, capital of eastern China's Anhui Province. The largest pharmaceutical enterprise in Anhui, we have been deemed as a high technology enterprise by both the Ministry of Science and Technology and Chinese Academy of Sciences. Moreover, we have also received national GMP certification, and been commended as a holder of a 'Trusted Drug Brand' by the Chinese government in 2006. Listed on the Shenzhen Stock Exchange on September 4, 2000, after obtaining the approval of the China Securities Regulatory Commission, we now have more than 5,000 employees and total capital of around RMB2.0 billion.

Engaged in pharmaceutical R&D, production and sales, we have five pharmaceutical plants and 45GMP certified production lines. Manufacturing biological pharmaceuticals, chemical pharmaceuticals and traditional Chinese medicines, our main series include antipyretic analgesic drugs, antibiotics, anti-tumor drugs, traditional Chinese medicine preparations, cardiovascular drugs, amino acids, oxytocic drugs, gonadotropic drugs, anti-ulcer drugs and nervous system drugs. Producing 11 formulations, including small and large volume injections, powder injections, capsules, powders, tablets, granules, films, eye drops and patches, we have 395 individual products and many types of raw materials available.

Now having more than 40 varieties of drugs under research or in development, some of these models have already entered the domestic market. Holding independent intellectual property rights for both our pharmaceuticals and processing technologies, we guarantee that all products are of the highest quality.

Boasting sales offices in more than 30 provinces, municipalities and autonomous regions around China, we are also exporting some products to clients in Southeast Asia, Africa, and South America. Continually seeking new distributors, we look forward to receiving all your detailed inquiries in the near future.